logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > 2,6-Dichloro-5-fluoro-3-pyridinecarbonitrile CAS 82671-02-1

2,6-Dichloro-5-fluoro-3-pyridinecarbonitrile CAS 82671-02-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 82671-02-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 82671-02-1 2

,

6-Dichloro-5-fluoro-3-pyridinecarbonitrile

,

2

,

6-Dichloro-5-fluoro-3-pyridinecarbonitrile

CAS No::
82671-02-1
Appearance::
Grayish White To Yellowish Brown Crystalline Solids
Molecular Formula::
C6HCl2FN2
Molecular Weight::
190.99
EINECS NO::
628-096-5
MDL NO::
MFCD01863289
CAS No::
82671-02-1
Appearance::
Grayish White To Yellowish Brown Crystalline Solids
Molecular Formula::
C6HCl2FN2
Molecular Weight::
190.99
EINECS NO::
628-096-5
MDL NO::
MFCD01863289
2,6-Dichloro-5-fluoro-3-pyridinecarbonitrile CAS 82671-02-1

Product Description:

Product Name:2,6-Dichloro-5-fluoro-3-pyridinecarbonitrile CAS 82671-02-1

 

 

Synonyms:

Cyano-2,6-dichloro-5-fluoropyridine, 2,6-Dichloro-5-fluoropyridine-3-carbonitrile;

3-Pyridinecarbonitrile,2,6-dichloro-5-fluoro-;

 

 

Chemical & Physical Properties

Appearance:Grayish white to yellowish brown crystalline solids

Assay: 99%+

Melting point:89-91℃

Boiling point:267.8±35.0℃

Flash point:115.8℃

Density:1.6175g/cm3

Pka:-6.91±0.1

 

 

Application

It is the intermediate of enoxacin.

Enoxacin is a broad-spectrum quinolone antibiotic developed by Daihon Pharmaceutical Co., LTD., which was first approved for marketing in Japan in 1986. By acting on the A subunit of bacterial DNA helicase, it inhibits DNA synthesis and replication, resulting in bacterial death. This product has a broad spectrum of antibacterial action, especially against aerobic gram-negative bacilli with high antibacterial activity, and has good antibacterial action against the following bacteria in vitro: most bacteria of the Enterobacteriaceae, including citrobacter, Clostridium, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It also has antibacterial activity against multi-drug resistant bacteria. The penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella have high antibacterial activity. It has antibacterial effect on most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive staphylococcus, and only moderate antibacterial activity against streptococcus pneumoniae, hemolytic streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, mycoplasma and Legionella, and also has antibacterial activity against tuberculosis bacillus and atypical Mycobacterium. Poor antibacterial activity against anaerobic bacteria. It is used to treat urinary, reproductive system, respiratory tract, digestive system, skin soft tissue, ear, nose, throat and eye infection caused by various bacteria and viruses.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.